retatrutide clinical trials safety How to Get in 2026 Unapproved weight-loss drug "reta" sold

Possible Side Effects Most studies report that AOD-9604 has a relatively mild safety profile

Ive seen this firsthand, not just with clients, but on my own shelf (yes, Ive used it too during my hormonal breakout phase)

Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)

Like we check our patients lipid profiles every 90 days because people will go on, you know, theyll go off on tangents and I can, I can generally tell when theyve gone off on a tangent and, and theyre, theyre eating it just like red meat every single day

Guzmn, C